15-16 November 2024, Protea Hotel OR Tambo, Kempton Park Johannesburg, South Africa
MASAC Educational Symposium offers an unparalleled platform for advancing knowledge, collaboration, and innovation in the field of haemophilia and bleeding disorders. With a rich history dating back to 1995, this symposium has played a pivotal role in ensuring accurate diagnosis and optimal treatment for individuals with bleeding disorders, thanks to the involvement of multi-disciplinary teams in South Africa.
MASAC IMPACT 1995-2023
We are excited to announce the dates for this year's SAHF MASAC Educational Symposium. SAHF MASAC Educational Symposium 2024 will be held from the 15th - 16th of November. This year's theme is "A Return to Patient-Centred Care"
The symposium features a diverse range of sessions, including keynote speeches, panel discussions, interactive workshops, and scientific presentations covering topics such as gene therapy and new therapies, point of care testing and acquired bleeding disorders to mention a few. Renowned experts and thought leaders from the field of haemophilia and bleeding disorders will share their insights and expertise, providing attendees with a comprehensive understanding of the latest advancements and best practices.
Read more articles, news from the world of haemophilia and other bleeding disorders.
TSAHF MASAC Educational Symposium 2024 – Day 1 Recap: A Full House and A Celebratory Milestone
The SAHF MASAC Educational Symposium early bird registrations are now open!
The SAHF MASAC Educational Symposium Call for Applications is now open!
The 2024 International Hemophilia Training Centre (IHTC) Fellowships Call for Applications is now open! The IHTC Fellowship Program provides training in all aspects of bleeding disorders management for healthcare professionals in developing countries. Since the Program was launched in 1972, nearly 800 healthcare professionals from more than 100 countries have received training..
For 60 years, hemophilia treatment has advanced dramatically. Unfortunately, the World Health Organization’s (WHO) 2023 Essential Medicines List (EML) does not reflect current international clinical guidelines for hemophilia. The World Federation of Hemophilia (WFH) is gravely concerned about this development, and the leading experts involved in our organization have published an article in The Lancet Haematology outlining our standpoint.
Drs Pasi and Mahlangu discuss the prospects for gene therapy for hemophilia..
Upcoming events
